Discussion in 'Stocks' started by ptrjon, May 4, 2010.
Pfizer estimates next years earnings at over $2 per share. Will this go to $25-$30?
They need to put something in their pipeline to smoke. Its too late for that.
There is no blockbuster's going forward. Wyeth is a research oriented firm, and PFE is more or less a Marketing firm. It was designed to save money now, and pad some investment bankers accounts.
Going forward even with a shorter time horizon, these synergies will get eaten up and the obvious facts will appear, namely that PFE has no organic growth, because the pipeline in the entire industry is empty.
Hmmm, musta been brought up cuz it's up in a down market. My parent's cat is captitvated by shiney things.
PFE is a ho hum defensive stock. A place to hide when the going gets tufff.
Wyeth? Research? It was the former American Home Products. Can you say Suzie Chapstick?
Yes, empty pipeline and 17 year patents expiring one by one. That bodes well for Perrigo and Mylan.
Separate names with a comma.